The mechanism by which HF reduces fibrosis was recently elucidated in a mouse model for scleroderma (dermal fibrosis), where a low dose of halo blocked TGF-β mediated SMAD3 activation in fibroblasts[47]. Here, TGFB1 is linked to scleroderma.